Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection

The increased prevalence of pulmonary methicillin-resistant Staphylococcus aureus (MRSA) infection in patients living with cystic fibrosis (CF) is concerning due to a correlation with reduced life expectancy and lack of available treatment options. RV94 is a next generation lipoglycopeptide designed...

Descripción completa

Detalles Bibliográficos
Autores principales: Konicek, Donna M., Plaunt, Adam J., Gharse, Sachin, Rose, Sasha J., Dorfman, Arielle, Sabnis, Amruta, Baker, Thomas, Gauani, Helena, Chun, Donald, Li, Zhili, Perkins, Walter R., Cipolla, David, Malinin, Vladimir S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537538/
https://www.ncbi.nlm.nih.gov/pubmed/37765219
http://dx.doi.org/10.3390/pharmaceutics15092250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537538/
https://www.ncbi.nlm.nih.gov/pubmed/37765219
http://dx.doi.org/10.3390/pharmaceutics15092250

Ejemplares similares